All Comparisons/Waystar vs Aspirion

VNDRIQ — Vendor Comparison

Waystar vs Aspirion

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Waystar45
Aspirion63

Waystar

Revenue Cycle

Last verified: August 18, 2026

Aspirion

Revenue Cycle

Verification pending

VNDRIQ Scores

45

Overall

Privacy Score52
Governance Score33
Healthcare Readiness44
AI Risk Score50

63

Overall

Privacy Score50
Governance Score71
Healthcare Readiness77
AI Risk Score55

Approval Tier

Restricted / Review Required
Approved With Restrictions

BAA Status

Verify Directly
Yes, as a Business Associate providing RCM services to covered entities, Aspirion enters into BAAs to manage PHI.

PHI Exposure Risk

High

AI Training Risk

Medium

HIPAA Risk Level

Low

Review Frequency

—

Quarterly

Recommended Use

—

Management of complex claims, clinical denials, payment variance, and underpayment recovery.

Restrictions

—

Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.

Executive Summary

Waystar

Revenue Cycle

Waystar is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Unknown and AI training risk is Unknown.

52

Privacy

33

Governance

44

Healthcare

50

AI Risk

Aspirion

Revenue Cycle

Aspirion is classified as Approved With Restrictions with a BAA status of Yes, as a Business Associate providing RCM services to covered entities, Aspirion enters into BAAs to manage PHI.. PHI exposure is rated High and AI training risk is Medium. Management of complex claims, clinical denials, payment variance, and underpayment recovery.

50

Privacy

71

Governance

77

Healthcare

55

AI Risk

Recommended For

Waystar

Currently under review — not recommended for active PHI deployment

Aspirion

Management of complex claims, clinical denials, payment variance, and underpayment recovery.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

Waystar

BAA has not been confirmed. Execute BAA before processing PHI.

Aspirion

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Use is restricted to authorized revenue cycle and financial personnel; requires a signed Business Associate Agreement (BAA) and adherence to HITRUST-certified workflows.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.